Drug may help reduce prostate cancer risk Published: Feb. 27, 2009 at 11:32 PM LINTHICUM, Md., Feb. 27 (UPI) -- Healthy men screened regularly for prostate cancer who show no symptoms should talk

FDA Provides PDUFA Target Agency Action Date For GTx’s Toremifene 80 mg NDA MEMPHIS, Tenn.--(BUSINESS WIRE)--GTx, Inc. (Nasdaq: GTXI), today announced that the United States Food and Drug Administr

Prostate Cancer Diagnosis: Should Patients with Prostate Specific Antigen >10ng/mL Have Stratified Prostate Biopsy Protocols? - Abstract Thursday, 05 March 2009 Department of Urology,

New Drug Helps Slow Prostate Cancer Study Shows Abiraterone Is Effective Against Hard-to-Treat Tumors By Charlene Laino WebMD Health News Reviewed by Louise Chang, MD Feb. 27, 2009 (Orlando, Fla.)

Synta gets $10 million cancer drug payment February 17, 2009 11:48 Synta Pharmaceuticals Corp. of Lexington said it received a $10 million payment from GlaxoSmithKline PLC, its partner in develop

January 20, 2009 Wayne State prof wins $564,000 grant to study metabolic syndrome Another half million dollars in federal funding is coming to Wayne State University for research. The U.S. Dep